1: Home (ALT-H)
2: HMA Joint (ALT-M)
- 2.1: Heads of Agencies (ALT-E)
3: Human Medicines (ALT-U)
4: Veterinary Medicines (ALT-V)

You are here: HMA Joint > Heads of Agencies > HMA Topics > Benchmarking of European Medicines Agencies

2.1.1: About HMA (ALT-O)
2.1.2: The Approval system (ALT-T)
2.1.3: HMA Topics (ALT-P)
- 2.1.3.1: HMA Working Group on Product Testing (ALT-W)
- 2.1.3.2: HMA Strategy Paper (ALT-S)
- 2.1.3.3: Joint HMA/EMEA Training Project Team (ALT-J)
- 2.1.3.4: Benchmarking of European Medicines Agencies (ALT-N)
- 2.1.3.5: Availability of Medicines (ALT-I)
- 2.1.3.6: Telematics (ALT-L)
2.1.4: Stakeholder Information (ALT-K)
2.1.5: HMA Calendar (ALT-C)
2.1.6: FAQ (ALT-Q)
2.1.7: Contact form (ALT-R)
2.1.8: Contact Points
2.1.9: Recruitment

Benchmarking of European Medicines Agencies

Executive Summary on the Outcome of the 1st Cycle (15.11 kb) December 2006

Report on the Outcome of the 1st Bench marking (BEMA) cycle (67.5 kb) December 2006

Benchmarking of European Medicines Agencies - Overview and summary (31.74 kb) May 2005